HRSA continues to make COVID-19 claims reimbursement to health care entities for the testing and treatment of uninsured individuals. The program is also reimbursing providers for administering COVID-19 vaccines to uninsured individuals. Starting last week, HRSA began adding claims information related to COVID-19 vaccine administration. As of March 3, 2021, HRSA has reimbursed over $2 billion in testing claims, $2 billion in treatment claims and newly added is approximately $750 thousand in vaccine administration claims for the uninsured.
A listing of health care entities that have agreed to the program’s Terms and Conditions and received claims reimbursement is now available from CDC.